BEYOND ENDEMIC CHRONIC KIDNEY DISEASE(CKDu) – THE LANDSCAPE OF CKD IN SRI LANKA

RA ABEYSEKERA1,2,3, HG HEALY3,4,5, IB GAWARAMMANA2, WE HOY3,6

1Centre for Education Research Training in Kidney Disease (CERTKiD), Faculty of  Medicine, University of Peradeniya, , Sri Lanka, 2Faculty of Medicine, University of Peradeniya, , Sri Lanka, 3Faculty of Medicine, University of Queensland, Brisbane, Australia, 4Kidney Health Services, Metro North Hospital and Health Service, , Australia, 5Queensland Institute of Medical Research, Kidney Research Laboratory, Brisbane, Australia, 6Centre for Chronic Disease, Centre for Clinical Research, University of Queensland, Brisbane, Australia

Aim

To identify the burden of CKD beyond CKDu in Sri Lanka.

Background

CKD epidemiological patterns vary significantly across the globe. Understanding local patterns is crucial for prevention, early diagnosis, improved outcomes and optimum resource allocation. Sri Lanka is experiencing a rise in non-communicable diseases, including CKD. Media and geo-political institutions are focusing on CKDu in the region, overlooking the potentially bigger problems of CKD driven by particularly diabetes and hypertension. Rightly so CKDu has been heavily investigated. It is limited to certain regions in the country where its prevalence, even in the highest risk areas, is only 2.44-4.35% of the population (Ministry of Health 2019 estimates). Very little is known about the rest of the country.

Methods

A pilot study will be conducted over 2 years in the Kandy district, using a three-armed mixed method design. Kandy is a non-CKDu endemic region, with approximate population of 1.5 million. Study arm one will establish a regional CKD registry and study CKD related disease patterns. Study arm two will describe community rates of CKD through the conduct of a prevalence study. Study arm three will profile prevalence of CKD within nephrology and non-nephrology medical  settings in a selected group of nationally representative hospitals through a standard survey questionnaire of specialists.

Conclusions

This would be the first representative profile of all CKD in Sri Lanka. It will describe the burden of CKD and its load within the health system in Sri Lanka, giving a perspective of CKDu in the burden. The pilot is proof of concept of greater precision mapping of CKD and its resource utilization across the country.


Biography:

Dr. Rajitha Abeysekera is a consultant Nephrologist and a Senior Lecturer in Medicine at Faculty of Medicine, University of Peradeniya, Sri Lanka. He is also the current Director of the Centre for Education Research Training in Kidney Disease (CERTKiD) of the Univeristy of Peradeniya. He has a keen interest in research related CKD, CKD epidemiology, AKI and Critical care nephrology.

Categories